hALK.CAR T Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for hALK.CAR T Cells, covering 2025-12-26 to 2025-12-26. Get the full timeline:
Most recent: Clinical Trial Update: Study of hALK.CAR T Cells for Patients With Relapsed/Refractory High-risk Neuroblastoma [Phase 1, Phase 2]